Drug Enforcement D-395-2014

Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.

Status

Terminated

Classification

Class II

Report Date

January 8, 2014

Termination Date

November 10, 2014

Product Information

Product description
0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 50 mL, Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045. NDC #0409-9046-01.
Product quantity
65109 vials
Reason for recall
Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
US Nationwide.

Location & Firm

Recalling firm
Hospira Inc.
Address
375 N Field Dr

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-395-2014
Event ID
67045
Recall initiation date
October 11, 2013
Center classification date
January 2, 2014
Code info
Lot #32-484-EV, 32-485-EV Exp: 2/2015.
More code info